Gintonin Isolated from Ginseng Inhibits the Epithelial—Mesenchymal Transition Induced by TGF-β in A549 Lung Cancer Cells

Epithelial-to-mesenchymal transition (EM transition) is a process wherein epithelial cells lose their intrinsic characteristics and cell–cell junctions and differentiate into a mesenchymal phenotype. EM transition is an important feature of cancer invasion and metastasis. In this study, we aimed to investigate the inhibitory effect of gintonin (GT), an ingredient of ginseng, on EM transition using A549 cells. The proliferation of A549 cells was enhanced following treatment with 50, 75, and 100 μg/mL of GT. GT affected EM transition-induced gene and protein expression, specifically that of vimentin (Vim), N-cadherin (N-cad), zinc finger E-box-binding homeobox 1, and Twist in A549 cells. Furthermore, the transforming growth factor beta 1 (TGF-β1)-induced phosphorylation of Smad2 and Smad3 was suppressed by GT treatment. Immunofluorescence staining also showed that GT treatment decreased the TGF-β1-induced expression of Vim and N-cad in A549 cells. Therefore, GT may be used to suppress cancer cell metastasis via maintenance of the cell–cell junction’s integrity. However, further studies are required to pave the way for its translation into clinical application in cancer therapeutics.

[1]  Chang Liu,et al.  Potential Oral Health Benefits of Ginseng and Its Extracts , 2023, International dental journal.

[2]  Sun-Hye Choi,et al.  Wound Healing Effect of Gintonin Involves Lysophosphatidic Acid Receptor/Vascular Endothelial Growth Factor Signaling Pathway in Keratinocytes , 2021, International journal of molecular sciences.

[3]  Sun-Hye Choi,et al.  The Gintonin-Enriched Fraction of Ginseng Regulates Lipid Metabolism and Browning via the cAMP-Protein Kinase a Signaling Pathway in Mice White Adipocytes , 2020, Biomolecules.

[4]  M. Kim,et al.  Ongoing Research on the Role of Gintonin in the Management of Neurodegenerative Disorders , 2020, Cells.

[5]  M. Fares,et al.  Molecular principles of metastasis: a hallmark of cancer revisited , 2020, Signal Transduction and Targeted Therapy.

[6]  M. Schabath,et al.  Cancer Progress and Priorities: Lung Cancer , 2019, Cancer Epidemiology, Biomarkers & Prevention.

[7]  V. Mittal.  Epithelial Mesenchymal Transition in Tumor Metastasis. , 2018, Annual review of pathology.

[8]  Sun-Hye Choi,et al.  Gintonin Administration is Safe and Potentially Beneficial in Cognitively Impaired Elderly , 2017, Alzheimer disease and associated disorders.

[9]  Byung-Hwan Lee,et al.  Gintonin attenuates depressive-like behaviors associated with alcohol withdrawal in mice. , 2017, Journal of affective disorders.

[10]  Byung-Hwan Lee,et al.  Effects of gintonin-enriched fraction on hippocampal cell proliferation in wild-type mice and an APPswe/PSEN-1 double Tg mouse model of Alzheimer's disease , 2016, Neurochemistry International.

[11]  C. Zappa,et al.  Non-small cell lung cancer: current treatment and future advances. , 2016, Translational lung cancer research.

[12]  Byung-Hwan Lee,et al.  Gintonin enhances performance of mice in rotarod test: Involvement of lysophosphatidic acid receptors and catecholamine release , 2016, Neuroscience Letters.

[13]  K. Kang,et al.  Sanguiin H6 suppresses TGF-β induction of the epithelial-mesenchymal transition and inhibits migration and invasion in A549 lung cancer. , 2015, Bioorganic & medicinal chemistry letters.

[14]  Hyeonseok Ko.  Geraniin inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses A549 lung cancer migration, invasion and anoikis resistance. , 2015, Bioorganic & medicinal chemistry letters.

[15]  Sang Myung Lee,et al.  Characterization of Korean Red Ginseng (Panax ginseng Meyer): History, preparation method, and chemical composition , 2015, Journal of ginseng research.

[16]  Ho-Chul Shin,et al.  Gintonin, a novel ginseng-derived lysophosphatidic acid receptor ligand, stimulates neurotransmitter release , 2015, Neuroscience Letters.

[17]  D. Medici,et al.  Signaling mechanisms of the epithelial-mesenchymal transition , 2014, Science Signaling.

[18]  Samy Lamouille,et al.  Molecular mechanisms of epithelial–mesenchymal transition , 2014, Nature Reviews Molecular Cell Biology.

[19]  Hyung Gyun Kim,et al.  Saponins from the Roots of Platycodon grandiflorum Suppresses TGFβ1-Induced Epithelial-Mesenchymal Transition Via Repression of PI3K/Akt, ERK1/2 and Smad2/3 Pathway in Human Lung Carcinoma A549 Cells , 2014, Nutrition and cancer.

[20]  S. Nah,et al.  Yin and Yang of ginseng pharmacology: ginsenosides vs gintonin , 2013, Acta Pharmacologica Sinica.

[21]  Jiyeon Kim,et al.  CK2 Inhibitor CX-4945 Blocks TGF-β1-Induced Epithelial-to-Mesenchymal Transition in A549 Human Lung Adenocarcinoma Cells , 2013, PloS one.

[22]  Hyeonseok Ko,et al.  TGF-β1-induced epithelial-mesenchymal transition and acetylation of Smad2 and Smad3 are negatively regulated by EGCG in human A549 lung cancer cells. , 2013, Cancer Letters.

[23]  W. Travis,et al.  New pathologic classification of lung cancer: relevance for clinical practice and clinical trials. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  H. Ford,et al.  Molecular Pathways Molecular Pathways : Targeting the TGF-b Pathway for Cancer Therapy , 2012 .

[25]  M. Tatari,et al.  EMT as the ultimate survival mechanism of cancer cells. , 2012, Seminars in cancer biology.

[26]  Ho-Chul Shin,et al.  Gintonin, newly identified compounds from ginseng, is novel lysophosphatidic acids-protein complexes and activates G protein-coupled lysophosphatidic acid receptors with high affinity , 2012, Molecules and cells.

[27]  Ming-chuan Zhao,et al.  Transforming growth factor-β1 promotes lung adenocarcinoma invasion and metastasis by epithelial-to-mesenchymal transition , 2011, Molecular and Cellular Biochemistry.

[28]  Byung-Hwan Lee,et al.  A Simple Method for the Preparation of Crude Gintonin from Ginseng Root, Stem, and Leaf , 2011, Journal of ginseng research.

[29]  Sarah Spiegel,et al.  International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid Receptor Nomenclature , 2010, Pharmacological Reviews.

[30]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[31]  Raghu Kalluri,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[32]  J. Massagué,et al.  TGFβ in Cancer , 2008, Cell.

[33]  Héctor Peinado,et al.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? , 2007, Nature Reviews Cancer.

[34]  S. Jakowlew.  Transforming growth factor-β in cancer and metastasis , 2006, Cancer and Metastasis Reviews.

[35]  J. Massagué,et al.  The logic of TGFβ signaling , 2006 .

[36]  Ying E. Zhang,et al.  Smad-dependent and Smad-independent pathways in TGF-β family signalling , 2003, Nature.

[37]  W. Fiers,et al.  Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role , 1991, Cell.

[38]  Ho-Chul Shin,et al.  Suppression of metastasis of intravenously-inoculated B16/F10 melanoma cells by the novel ginseng-derived ingredient, gintonin: involvement of autotaxin inhibition. , 2013, International journal of oncology.

[39]  Hyoung-Chun Kim,et al.  Gintonin, a ginseng-derived lysophosphatidic acid receptor ligand, attenuates Alzheimer's disease-related neuropathies: involvement of non-amyloidogenic processing. , 2012, Journal of Alzheimer's disease : JAD.